Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Jasper Therapeutics M&A Deal with Kira Pharmaceuticals
Jasper Therapeutics, Inc. filed an amendment to its previous 8-K to include required financial statements and pro forma information following its completed acquisition of Kira Pharmaceuticals. The transaction was structured as a merger where Kira merged into a wholly owned subsidiary of Jasper, and the filing also references a concurrent private placement of preferred stock and a license agreement with Mirador.
Curaleaf Holdings announced its addition to the FTSE Canada All Cap Index, effective September 18, 2026. This marks the company's second major Canadian benchmark inclusion following its 2025 addition to the S&P/TSX Composite Index, which management expects will increase liquidity and institutional investor exposure.
Axogen M&A Deal with BioCircuit Technologies, Inc.
Axogen, Inc. has completed its acquisition of BioCircuit Technologies, Inc., a developer of NerveTape™, the first FDA-cleared sutureless device for peripheral nerve repair. The acquisition is expected to contribute approximately $34 million to Axogen's 2027 revenue and aligns with the company's mission to restore peripheral nerve function.
Corteva, Inc. completed the spin-off of its Seed Business into an independent publicly traded company named Vylor Inc. via a pro rata dividend in-kind to shareholders. Due to accounting rules, Vylor is treated as the accounting successor, and this filing provides the historical combined financial statements for 'New Corteva,' which now consists solely of the Crop Protection Business.
Pyxis Oncology closed an underwritten public offering of 36,047,919 shares of common stock and pre-funded warrants, along with accompanying common warrants, at a combined price of $2.90 per share. The offering raised approximately $110 million in gross proceeds before expenses. The common warrants will only become exercisable upon stockholder approval of a charter amendment to increase the company's authorized share count.
Aethlon Medical held its Annual Meeting of Stockholders on October 1, 2026, where shareholders elected five directors and ratified Haskell & White LLP as the independent auditor. Stockholders also approved an amendment to the 2020 Equity Incentive Plan to increase the authorized share pool by 100,000 shares and approved the potential issuance of shares related to warrants from a July 2026 offering.
Bain Capital Private Credit priced a private placement of $350 million in 7.600% senior notes due 2031. The company intends to use the proceeds for general corporate purposes, including the repayment of existing indebtedness under its revolving credit facilities and making new portfolio investments.
Workday $1.5B Debt Financing with Wells Fargo Bank, National Association
Workday, Inc. entered into a new $1.5 billion revolving credit agreement with a syndicate of lenders led by Wells Fargo, replacing its previous $1.0 billion facility. The new facility has a maturity date of October 1, 2031, and provides the company with increased liquidity for general corporate purposes.
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $1.06M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 1,920 shares of United Therapeutics Corp at $547.29 to $554.70 a share (average $550.22) in 8 transactions, worth $1.06M in total on Sep 30, 2026. Shares held after the trade: 324,443 (-0.1%).
CNL Strategic Residential Credit Capital Raise of $6.73M
CNL Strategic Residential Credit, Inc. raised approximately $6.73 million in a private offering during September 2026. The company issued 273,277 shares of Class FA common stock and 4,008 shares of Class E common stock under Rule 506(c) of Regulation D. No selling commissions or managing dealer fees were paid in connection with these specific sales.
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $3.93M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 7,580 shares of United Therapeutics Corp at $476.14 to $546.23 a share (average $517.97) in 24 transactions, worth $3.93M in total on Sep 30, 2026. Shares held after the trade: 331,103 (-0.0%).
Aureus Greenway Holdings M&A Deal with Autonomous Power Corporation
Aureus Greenway Holdings Inc. (AGH) completed its merger with Autonomous Power Corporation (Legacy Powerus), with the combined entity renamed Powerus Corporation. In connection with the closing, the company issued approximately 134.6 million shares of common stock to Legacy Powerus stockholders, who now hold approximately 93% of the voting power. The combined company continues to trade on the Nasdaq Capital Market under the ticker PUSA.
Kymera Therapeutics CEO Nello Mainolfi Sells $3.41M of Stock
Nello Mainolfi, CEO, sold 30,000 shares of Kymera Therapeutics, Inc. at $111.44 to $116.12 a share (average $113.80) in 6 transactions, worth $3.41M in total on Oct 1, 2026. Shares held after the trade: 666,568 (-0.0%).
Synaptics and onsemi have entered into an amended and restated merger agreement where onsemi will acquire Synaptics for $123 per share in cash, valuing the deal at approximately $5.7 billion. The revised agreement follows an unsolicited competing proposal from a third party and shifts the deal structure from the original June 2026 agreement to an all-cash transaction. The deal is expected to close by mid-2027 and is projected to be immediately accretive to onsemi's non-GAAP EPS.
Endra Life Sciences M&A Deal with ASP Isotopes Inc.
ENDRA Life Sciences entered into a first amendment to its previously announced merger agreement with ASP Isotopes Inc. and Noble Africa LLC. The amendment modifies the minimum cash closing condition to approximately $3.8 million, removes classified board requirements, and increases the borrowing capacity of the target's subsidiary, Renergen, up to $200 million.
CNL Strategic Residential Credit Insider James M. Seneff Jr. Buys $5M of Stock
James M. Seneff Jr. bought 206,101 shares of CNL Strategic Residential Credit, Inc. at $24.26 a share, worth $5M in total on Sep 30, 2026. Shares held after the trade: 306,101 (+206.1%).
Highlands REIT, Inc. announced the final results of its self-tender offer, purchasing 135,380,970.82434 shares of its common stock at $0.20 per share. The company increased the number of shares accepted for purchase to accommodate the oversubscription, resulting in an aggregate cost of approximately $27.1 million. The repurchased shares represent approximately 18.7% of the company's outstanding common stock as of the commencement of the offer.
Michael K. Korenko, CEO, bought 200,000 shares of Vivos Inc at $0.498 a share, worth $99.6K in total on Sep 30, 2026. Shares held after the trade: 11,635,090 (+1.7%).
SKYX Platforms Corp. received a deficiency notice from Nasdaq after falling out of compliance with board and audit committee independence requirements following the passing of director Efrat L. Greenstein Brayer. The company has been granted a cure period to regain compliance that extends until the earlier of its next annual meeting or September 26, 2027. The notice has no immediate effect on the listing of the company's common stock.
Pelthos Therapeutics held its 2026 Annual Meeting of Stockholders where shareholders elected eight directors to serve until the 2027 meeting and ratified Grant Thornton LLP as the independent auditor for fiscal year 2026. Additionally, stockholders approved the 2026 Equity Incentive Plan, which replaces the company's previous 2023 plan.
On Semiconductor Signs $5.7B M&A Deal with Synaptics Incorporated
onsemi has amended its definitive agreement to acquire Synaptics, shifting the deal structure to an all-cash transaction valued at $123 per share, or approximately $5.7 billion. The revision follows an unsolicited competing proposal from a third party and is expected to be immediately accretive to onsemi's non-GAAP EPS upon closing, which is anticipated by mid-2027.
Value
$5.7B
Counterparty
Synaptics Incorporated
“As was the case when we initially announced the acquisition, Synaptics addresses an important aspect of our strategic direction, and we believe the revised merger agreement represents a more financially attractive transaction for our shareholders.”
Hassane El-Khoury, President and CEO of onsemi
“Our Board has been singularly focused on delivering the best outcome for our shareholders, and today's amended agreement reflects that commitment.”
Teads Holding Co. expanded its Board of Directors from ten to eleven members and appointed Stuart Kovensky as a Class I director. Mr. Kovensky, an experienced investment management executive and founder of Cogent Advisory LLC, will serve on the Financing Committee and receive a monthly cash retainer of $40,000. His appointment is intended to support the company's ongoing initiatives to optimize its capital structure and enhance financial flexibility.
Traeger, Inc. appointed David R. Jolley to its Board of Directors as a Class III director, effective October 1, 2026. Mr. Jolley will serve on the audit and compensation committees and will receive compensation under the company's existing program for non-employee directors, which includes eligibility for the company's Deferred Compensation Plan.
Adagio Medical Holdings reported that a holder of its 13% Senior Secured Convertible Notes converted $776,111 in aggregate principal into 4,978,869 shares of common stock. The conversion occurred at prices ranging from $0.1265 to $0.1618 per share following the company's election to lower the conversion price to an 'Alternate Conversion Price' through October 31, 2026. This transaction represents the settlement of existing debt obligations through equity issuance with no new cash proceeds received.
Veritone, Inc. is conducting a registered direct offering of 20,000,000 shares of its common stock to certain purchasers. The offering is being made under an existing shelf registration statement on Form S-3 and a related prospectus supplement.
Federal Home Loan Bank of San Francisco Shareholder Meeting
The Federal Home Loan Bank of San Francisco completed its 2026 director elections for member directorships. Michael Boden was elected as the Arizona member director and Chang Liu was re-elected as the California member director, both for four-year terms beginning January 1, 2027.
KBR, Inc. appointed Rami Qasem to its Board of Directors, effective October 1, 2026, with a term expiring at the 2027 annual meeting. Mr. Qasem brings nearly 30 years of international leadership experience from roles at Baker Hughes and General Electric. The appointment comes as KBR prepares for the planned separation of its Mission Technology Solutions business (Trinzic) in January 2027.
AIB Data Centers entered into a binding Master Colocation Services Agreement with Nebius for 50 MW of critical IT capacity at its facility in the southeastern United States. The initial 12-year term includes customer prepayments intended to fund a substantial portion of development costs, reducing the need for dilutive equity financing.
Sizzle Acquisition Corp. II M&A Deal with Trasteel Holding S.A.
Sizzle Acquisition Corp. II announced that its merger partner, Trasteel S.A. (Pubco), has confidentially submitted a draft registration statement on Form F-4 with the SEC. This marks a key regulatory milestone for the previously announced business combination between the SPAC and the global steel trading group. Upon closing, the combined company is expected to list on Nasdaq under the ticker symbol TSTL.
James Hardie Industries plc has appointed Jennifer Kong-Picarello as an independent, Class III director, effective October 1, 2026. Ms. Kong-Picarello currently serves as the CFO of Terex Corporation and brings over 25 years of financial leadership experience from Schneider Electric, Honeywell, and Tyco. She is expected to join the company's Audit Committee in November 2026.